moderna covid-19 vaccine (spikevax)

Search results

- Moderna secures a second FDA vaccine approval as Spikevax sales plummet
  Fast Company Magazine· 3 days ago
  The vaccine will be Moderna’s second product to enter the U.S. market after the FDA’s approval of...
- US FDA approves Moderna’s RSV vaccine, its second marketed product
  WHTC 1450 Holland· 3 days ago
  By Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
- Moderna wins second product approval with RSV vaccine
  Market Watch· 3 days ago
  The Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
- FDA Approves First mRNA RSV Vaccine
  MedPage Today· 4 days ago
  The vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine (Spikevax).
- Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
  ETF DAILY NEWS· 4 days ago
  Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
- Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
  BioresearchOnline· 5 days ago
  Lipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and...